# Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Adult Human Volunteers

> **NCT01875939** · PHASE1 · COMPLETED · sponsor: **Wockhardt** · enrollment: 12 (actual)

## Conditions studied

- Effect of Food

## Interventions

- **DRUG:** Oral WCK2349
- **DRUG:** IV WCK771

## Key facts

- **NCT ID:** NCT01875939
- **Lead sponsor:** Wockhardt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01875939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01875939, "Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Adult Human Volunteers". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT01875939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
